Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.74 -0.13 (-2.67%)
At close: Oct 1, 2026 · 4:00 PM EDT

Taysha Gene Therapies (TSHA) Accumulated Depreciation (2020 - 2026)

Updated

Taysha Gene Therapies (TSHA) posted Accumulated Depreciation of $5.25 million for Q2 2026, up 28.1% from $4.1 million a year earlier and up 5.6% from the prior quarter.

Analysis

Taysha Gene Therapies (TSHA) Accumulated Depreciation (2020 - 2026) Analysis & Trends

At the end of FY2025, Taysha Gene Therapies' Accumulated Depreciation came in at $4.68 million, up 30.7% from FY2024.

  • Annual Accumulated Depreciation has increased for four consecutive years, with a five-year compound annual growth rate of 249.4% (FY2020 to FY2025).
  • In prior years, Taysha Gene Therapies' Accumulated Depreciation was $3.58 million in FY2024 (+20.3%), $2.98 million in FY2023 (+81.4%), $1.64 million in FY2022 (+229.1%) and $499,000 in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Accumulated Depreciation in data going back to Q4 2020.
  • On a year-over-year basis, Accumulated Depreciation has increased in each of the last 17 quarters, with growth averaging 24.7% over the last eight quarters.
  • The year-over-year growth in Accumulated Depreciation has ranged between 12.0% (Q3 2025) and 706.3% (Q2 2022) over the last five years.
  • According to Business Quant data, Accumulated Depreciation for the three prior quarters was $4.97 million (Q1 2026), $4.68 million (Q4 2025) and $4.39 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Taysha Gene Therapies 1.58 Bn 1.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.25 Mn
Mar 31, 2026 4.97 Mn
Dec 31, 2025 4.68 Mn
Sep 30, 2025 4.39 Mn
Jun 30, 2025 4.10 Mn
Mar 31, 2025 3.82 Mn
Dec 31, 2024 3.58 Mn
Sep 30, 2024 3.91 Mn
Jun 30, 2024 3.63 Mn
Mar 31, 2024 3.31 Mn
Dec 31, 2023 2.98 Mn
Sep 30, 2023 2.64 Mn
Jun 30, 2023 2.31 Mn
Mar 31, 2023 1.97 Mn
Dec 31, 2022 1.64 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.02 Mn
Mar 31, 2022 754,000.00
Dec 31, 2021 499,000.00
Sep 30, 2021 292,000.00
API Access

Taysha Gene Therapies Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=TSHA&period=max&api_key=YOUR_API_KEY